Kymera Therapeutics has seen a sharp reset in long term expectations, with the fair value estimate jumping from $77.59 to $114.00 even as modeled revenue growth is revised down from roughly -0.04% to ...
Cryptopolitan on MSN
Best crypto under $1 to accumulate ahead of a confirmed 20% price step-up
Moments like this tend to arrive quietly. Allocation tightens, development milestones align, and the next pricing tie ...
Press Trust of India on MSN
MoEngage secures additional $180 million in Series F funding; completes liquidity event for employees and investors
The round, led by ChrysCapital and Dragon Funds, underscores MoEngage's global momentum as enterprises move beyond legacy marketing clouds to adopt MoEngage's insights-led customer engagement platform ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback